To Top

Archives for: December 20th, 2019

NORD Welcomes Two New Members to Board of Directors

Written by Laura Mullen on December 20, 2019

Washington, DC, December 20, 2019—The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing over 25 million Americans with rare diseases, announces the appointment of two new members to its Board of Directors, effective immediately.

Joining the Board of Directors… Read More

NORD supports Dr. Stephen Hahn’s nomination for FDA commissioner

Written by Valaree DonFrancesco on November 1, 2019

On Friday, November 1, 2019, the White House announced the nomination of Dr. Stephen Hahn, MD, as the next US Food and Drug Administration (FDA) commissioner. In response, the National Organization for Rare Disorders (NORD) offers support to the appointment of Dr. Hahn as the next FDA commissioner.

Dr. Hahn will… Read More